77% of Surveyed Pharma Companies Use Ad Hoc Launch Sequencing Committees Instead of Dedicated Teams RESEARCH TRIANGLE PARK, NC--(Marketwired - June 30, 2016) - While executing a new drug launch, 77% of surveyed pharmaceutical companies look to ad hoc launch sequencing groups rather than maintaining...